Buehlmann


The Beckman Coulter Companies


Immunotech & DSL

Immunotech & DSL products excel in consistent quality, flexibility and the application of all official quality and safety standards.

Beckman Coulter’s immunoassay expertise is supported by Immunotech’s 20 years of designing and commercializing in vitro diagnostic products.

Immunotech develops and manufactures reagents intended for in vitro diagnostics and offers two different immunoassay formats, radioimmunoassay (RIA) and enzyme immunoassay (EIA) providing a broad menu for oncology, apoptosis, mediators, retrovirology, cytokines and more.

Researchers and Clinicians here in Switzerland are strongly relying on the competence of Immunotech for example in the fields of cytokine research, and of reproductive medicine by application of Androstenedione  and DHEA RIAs as well as the EIA for the ovarian marker anti Mullerian Hormone (AMH)* Literature

Another member of Beckman Coulter is Diagnostic Systems Laboratories (DSL) established in 1981 with a vision of developing and marketing high quality in vitro diagnostics. DSL is a worldwide leader in hormone analysis. By continually exploring new technologies and applications, DSL stays at the forefront of the in vitro diagnostic industry in terms of innovation and responsiveness to evolving laboratory procedures.

List of actually requested Immunotech & DSL EIA Products and of Immunotech & DSL RIA Products in Switzerland.

Visit Immunotech Homepage
Visit DSL Homepage

Contact

BÜHLMANN Laboratories AG
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch

Your local distributor
Order
About us
Job opportunities

News

BUHLMANN as gold sponsor of the 5th Santorini Pharmacogenetics Conference

Functional Genomics Towards Personalized Health Care The 5th Santorini Conference will take place in Thira, Greece, on September 30th , October 1st and 2  more

Measuring of Mineralwaters and Softdrinks on Arena and Aquakem

The high expectations in speed, accuracy and precision have been achieved in an evaluation study on Arena 30 at Feldschlösschen (Carlsberg Group), Rheinfe  more

BÜHLMANN Calprotectin Test introduced in Belgium

The Hartziekenhuis Hospital in Belgium introduced the BÜHLMANN Calprotectin Assay for testing of faecal samples of IBD patients. A thorough evaluation pro  more

Distribution of BioPorto’s NGAL ELISA

In January 2010 BÜHLMANN starts the distribution of the innovative diagnostic products of BioPorto in Switzerland , Austria and France .  more

Get our RSS - Feed